Expand PRAX Menu
PRAX MENU

PRAX Stock Posts


PRAX stock increases 9.5% after hours.

After Hours Gainer

PRAX Praxis Precision Medicines189.97+3.82+2.1%

After Hours:208.00+18.03 (+9.5%)

Praxis Precision Medicines Announces Positive Results from EMBOLD Study for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Globe NewswireThu, 4-Dec 4:10 PM

Unusual Option Volume

PRAX Praxis Precision Medicines166.42-5.93 (-3.4%)

Praxis Precision Medicines trades 3,751 contracts. The company has the following event: HC Wainwright Emerging Ideas on BioPharma on Nov 7, 2025.
Unusual Option Volume

PRAX Praxis Precision Medicines161.68-10.07 (-5.9%)

Praxis Precision Medicines trades 3,869 contracts. The company has the following event: American Epilepsy Society Annual Meeting on Dec 1, 2025. News: Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Unusual Option Volume

PRAX Praxis Precision Medicines173.24-25.52 (-12.8%)

Praxis Precision Medicines trades 7,236 contracts. The company has the following event: American Epilepsy Society Annual Meeting on Dec 1, 2025.
Unusual Option Volume

PRAX Praxis Precision Medicines171.73-18.26 (-9.6%)

Praxis Precision Medicines trades 2,964 contracts. The company has the following event: North American Cystic Fibrosis Conference (NACFC) between Oct 22, 2025 and Oct 25, 2025.
Unusual Option Volume

PRAX Praxis Precision Medicines187.00+24.29 (+14.9%)

Praxis Precision Medicines trades 4,583 contracts. The company has the following event: North American Cystic Fibrosis Conference (NACFC) between Oct 22, 2025 and Oct 25, 2025. News: Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering
Market Data Delayed 15 Minutes